The DOI matches its Crossref record.
Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation
Abstract
Monocyte chemoattractant protein-1 (MCP-1), a chemotactic cytokine, acts in vitro as a chemotactic and activating factor for multiple types of leukocytes. To determine the chemotactic and activating effects of MCP-1 in vivo, we constructed transgenic mice that express human MCP-1 in type II alveolar epithelial cells and secrete it into the bronchoalveolar space. We found that MCP-1 overexpression led to a marked increase in the numbers of both monocytes and lymphocytes that could be recovered by bronchoalveolar lavage. This accumulation of mononuclear leukocytes could be reversed by the administration of an MCP-1-blocking Ab. In spite of its chemotactic effect, MCP-1 expression did not cause the inflammatory activation of accumulated leukocytes. Lungs of MCP-1 transgenic mice also showed no morphologic evidence of inflammation. However, MCP-1 mice had an increased sensitivity to other inflammatory stimuli. MCP-1 mice treated with either i.p. LPS or i.v. yeast wall glucan developed consolidated pulmonary infiltrates consisting predominantly of macrophages. Nontransgenic mice developed no such infiltrates. These results demonstrate that MCP-1 is chemotactic for monocytes and lymphocytes in vivo and that MCP-1 expression alone does not cause inflammatory activation of cells, but leads to an enhanced inflammatory response upon treatment with other stimuli.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M., & Rollins, B. J. (2000) · Nature · doi:10.1038/35006097 · Cited by 832
Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor
Kurihara, T., Warr, G., Loy, J., & Bravo, R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1757 · Cited by 717
More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis
Gschwandtner, M., Derler, R., & Midwood, K. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02759 · Cited by 611
Gonzalo, J.-A., Lloyd, C. M., Wen, D., Albar, J. P., Wells, T. N. C., Proudfoot, A., Martinez-A, C., Dorf, M., Bjerke, T., Coyle, A. J., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.157 · Cited by 536
Role of Chemokines in CNS Health and Pathology: A Focus on the CCL2/CCR2 and CXCL8/CXCR2 Networks
Semple, B. D., Kossmann, T., & Morganti-Kossmann, M. C. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.240 · Cited by 457
Lin, K. L., Suzuki, Y., Nakano, H., Ramsburg, E., & Gunn, M. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2562 · Cited by 442
Self-citationMahad, D. J., & Ransohoff, R. M. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(02)00125-2 · Cited by 415
Human asymptomatic Ebola infection and strong inflammatory response
Leroy, E., Baize, S., Volchkov, V., Fisher-Hoch, S., Georges-Courbot, M.-C., Lansoud-Soukate, J., Capron, M., Debré, P., Georges, A., & McCormick, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02405-3 · Cited by 411
Mukaida, N., Harada, A., & Matsushima, K. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00022-1 · Cited by 401
The MCP/eotaxin subfamily of CC chemokines
Van Coillie, E., Van Damme, J., & Opdenakker, G. (1999) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00005-2 · Cited by 350
Monocyte Chemoattractant Protein-1
Gu, L., Tseng, S. C., & Rollins, B. J. (1999) · Chemical Immunology and Allergy · doi:10.1159/000058723 · Cited by 326
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
Goede, V., Brogelli, L., Ziche, M., & Augustin, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<765::aid-ijc23>3.0.co;2-f · Cited by 319
CCL2 (monocyte chemoattractant protein-1) and cancer
Conti, I., & Rollins, B. J. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.009 · Cited by 314
Chemokines in acute respiratory distress syndrome
Puneet, P., Moochhala, S., & Bhatia, M. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00405.2003 · Cited by 313
Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD
de Boer, W. I., Sont, J. K., van Schadewijk, A., Stolk, J., van Krieken, J. H., & Hiemstra, P. S. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200004)190:5<619::aid-path555>3.0.co;2-6 · Cited by 306
Metabolic syndrome is an inflammatory disorder: A conspiracy between adipose tissue and phagocytes
Reddy, P., Lent-Schochet, D., Ramakrishnan, N., McLaughlin, M., & Jialal, I. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.06.019 · Cited by 297
Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease
Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.538 · Cited by 289
Chen, Y., Hallenbeck, J. M., Ruetzler, C., Bol, D., Thomas, K., Berman, N. E. J., & Vogel, S. N. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000071885.63724.20 · Cited by 276
Role of Chemokines in the Pathogenesis of Acute Lung Injury
Bhatia, M., Zemans, R. L., & Jeyaseelan, S. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0392tr · Cited by 274
The multifaceted profile of activated microglia
Lynch, M. A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8077-9 · Cited by 268
The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?
Yoshimura, T. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2017.135 · Cited by 266
Tesch, G. H., Schwarting, A., Kinoshita, K., Lan, H. Y., Rollins, B. J., & Kelley, V. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4876 · Cited by 266
Inouye, K. E., Shi, H., Howard, J. K., Daly, C. H., Lord, G. M., Rollins, B. J., & Flier, J. S. (2007) · Diabetes · doi:10.2337/db07-0425 · Cited by 252
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease
Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C., Bresolin, N., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.007 · Cited by 209
Loss of IL-10 Promotes Differentiation of Microglia to a M1 Phenotype
Laffer, B., Bauer, D., Wasmuth, S., Busch, M., Jalilvand, T. V., Thanos, S., Meyer zu Hörste, G., Loser, K., Langmann, T., Heiligenhaus, A., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00430 · Cited by 120
Metadata
- Authors
- Gunn, M. D., Nelken, N. A., Liao, X., & Williams, L. T.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-01-01
- Volume
- 158
- Issue
- 1
- Pages
- 376-383
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1513606958
- Cited by
- 205
- References
- 0
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.